Seasoned biotechnology executive with 25 years market and portfolio management experience including development, registration, launch and commercialization across multiple therapeutic areas in the US and globally.
Senior Vice President, Worldwide Commercial Portfolio Strategy at Bristol Myers Squibb
MBA